Tenormin and Requip drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tenormin and Requip. Common interactions include muscle spasms among females and pain among males.

The phase IV clinical study analyzes what interactions people who take Tenormin and Requip have. It is created by eHealthMe based on reports of 86 people who take Tenormin and Requip from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 26, 2022

86 people who take Tenormin and Requip together, and have interactions are studied.


What is Tenormin?

Tenormin has active ingredients of atenolol. It is often used in high blood pressure. eHealthMe is studying from 20,074 Tenormin users for its effectiveness, alternative drugs and more.

What is Requip?

Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,080 Requip users for its effectiveness, alternative drugs and more.

Number of Tenormin and Requip reports submitted per year:

Tenormin and Requip drug interactions.

Common Tenormin and Requip drug interactions by gender *:

female:

  1. Muscle spasms
  2. Myalgia
  3. Diarrhoea
  4. Limb discomfort
  5. Balance disorder
  6. Contusion
  7. Cytolytic hepatitis
  8. Delirium
  9. Dizziness
  10. General physical health deterioration

male:

  1. Pain
  2. Oedema peripheral
  3. Erythema
  4. Exostosis
  5. Facet joint syndrome
  6. Fibrosis
  7. Infection
  8. Insomnia
  9. Intervertebral disc degeneration
  10. Iritis

Common Tenormin and Requip drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal pain
  2. Cholelithiasis
  3. Pulmonary embolism
  4. Truncus coeliacus thrombosis
  5. Aortic thrombosis
  6. Drug ineffective
  7. Leriche syndrome
  8. Premenstrual syndrome
  9. Thrombosis
  10. Activities of daily living impaired

40-49:

  1. Erythema
  2. Paraesthesia

50-59:

  1. Nephrotic syndrome
  2. Renal failure
  3. Renal infarct
  4. Vomiting
  5. Weight decreased
  6. Acute respiratory failure
  7. Anaemia
  8. Discomfort
  9. Feeling hot
  10. Gastrooesophageal reflux disease

60+:

  1. Dyspnoea
  2. Asthenia
  3. Renal failure
  4. Weight decreased
  5. Anorexia
  6. Aphonia
  7. Back pain
  8. Balance disorder
  9. Contusion
  10. Diarrhoea

Common conditions people have *:

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 8.14%
  2. Carcinoid Tumor Of The Caecum: 7 people, 8.14%
  3. Parkinson's Disease: 6 people, 6.98%
  4. Osteoporosis (bones weak and more likely to break): 5 people, 5.81%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 5.81%

* Approximation only. Some reports may have incomplete information.

Do you take Tenormin and Requip?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Tenormin and Requip interactions:

Browse all drug interactions of Tenormin and Requip:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Tenormin interactions:

Browse all interactions between Tenormin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Requip interactions:

Browse all interactions between Requip and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on atenolol and ropinirole hydrochloride (the active ingredients of Tenormin and Requip, respectively), and Tenormin and Requip (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Tenormin and Requip.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: